Androgens
Fluoxymesterone
An oral androgen with specific historical and medical uses; substantial androgen-related risks remain.
Established medical uses
Also known as: Halotestin · Androxy
Practical use
Applying the explained evidence
- Where it fits
- An oral androgen with specific historical and medical uses; substantial androgen-related risks remain.
- Put the information into practice
- Medical use depends on diagnosis, history and monitoring. The patient guide lists several discontinued brand names; the existence of a monograph does not prove a specific branded product is currently sold.
- Formulation and purpose
- Write down the exact compound and formulation behind a claim. Compare the studied population and purpose with the situation being discussed; evidence for medical replacement does not automatically answer a physique-enhancement question.
- Keep this limit in view
- Reported concerns include liver problems, fluid retention, mood changes, reduced male fertility and virilizing effects. High-exposure androgen misuse is associated with serious cardiovascular and psychiatric harms. Jaundice, persistent erections or breathing difficulty need prompt assessment.
Overview
Fluoxymesterone is an androgen medicine used for selected forms of hypogonadism, delayed puberty and some breast-cancer settings. A recognized medicine is not evidence of a safe enhancement strategy.
Risks and limitations
Reported concerns include liver problems, fluid retention, mood changes, reduced male fertility and virilizing effects. High-exposure androgen misuse is associated with serious cardiovascular and psychiatric harms. Jaundice, persistent erections or breathing difficulty need prompt assessment.
How to read this
Medical use depends on diagnosis, history and monitoring. The patient guide lists several discontinued brand names; the existence of a monograph does not prove a specific branded product is currently sold.
Research explained
No study-by-study summary has been added to this entry yet. Review the linked sources and the stated limitations.
Hormonal feedback and pharmacokinetics
The archived Halotestin label describes suppression of endogenous testosterone through pituitary LH feedback and potential suppression of spermatogenesis. It gives an approximate oral half-life of 9.2 hours. A clearance value does not quantify the time required for reproductive recovery or establish safe repeated exposure.
The same document describes androgen effects on red-cell production and fluid/electrolyte retention. These are systemic hormone effects; a desired strength effect cannot be assessed in isolation from them.
Supporting sourceSources
Sources checked 2026-09-28.
General education; not a personal treatment plan.